Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Respir Cell Mol Biol ; 25(1): 14-20, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11472970

RESUMO

Chloride (Cl(-)) movement across fetal lung epithelia is thought to be mediated by the sodium-potassium-2-Cl(-) cotransporter NKCC1. We studied the role of NKCC1 in Cl(-) and liquid secretion in late-gestation NKCC-null (-/-) and littermate control fetal mouse lung. NKCC -/- mice had decreased lung water compared with littermate controls (wet/dry: control, 8.01 +/- 0.09; NKCC -/-, 7.06 +/- 0.14). Liquid secretion by 17-d NKCC -/- distal lung explants was similar to control explants. Bumetanide inhibited basal liquid secretion in control but not NKCC -/- explants (expansion over 48 h: control, 35 +/- 4%; NKCC -/- 46 +/- 7%). Treatment with 4,4'-diisothiocyanto-stilbene-2,2'-disulfonic acid (DIDS) decreased liquid secretion in both control and NKCC -/- explants. Basal transepithelial potential difference (PD) of control tracheal explants was higher than that of NKCC -/- (control, -13.7 +/- 0.5 mV; NKCC -/-, -11.6 +/- 0.6 mV). Amiloride (10(-)(4) M) inhibited basal PD to the same extent in control and NKCC -/- mice. Terbutaline-stimulated hyperpolarization was less in NKCC -/- than in control tracheas (DeltaPD: control, -10.8 +/- 1.33 mV; NKCC -/-, -6.1 +/- 0.7 mV) and was inhibited by DIDS and acetazolamide in NKCC -/- but not wild-type explants. We conclude that NKCC is rate-limiting for transcellular Cl(-) transport, and that alternative anion transport mechanisms can sustain liquid production at near-normal levels in the fetal NKCC -/- mouse lung.


Assuntos
Proteínas de Transporte/fisiologia , Cloretos/metabolismo , Metabolismo dos Lipídeos , Pulmão/metabolismo , Traqueia/metabolismo , Animais , Carbonatos/metabolismo , Proteínas de Transporte/genética , Desenvolvimento Embrionário e Fetal , Células Epiteliais/metabolismo , Genótipo , Concentração de Íons de Hidrogênio , Hibridização In Situ , Técnicas In Vitro , Transporte de Íons , Pulmão/citologia , Pulmão/embriologia , Potenciais da Membrana , Camundongos , Simportadores de Cloreto de Sódio-Potássio , Traqueia/citologia , Traqueia/embriologia
2.
Am J Med Sci ; 321(1): 33-41, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11202478

RESUMO

Alpha1-antitrypsin (alpha1AT) deficiency is a common lethal hereditary disorder of white persons of European descent. The condition is characterized by reduced serum levels of alpha1AT, a 52-kDa glycoprotein synthesized chiefly in the liver and, to a lesser extent, by macrophages and neutrophils. Alpha1AT acts as an antiprotease and is the physiological inhibitor of neutrophil serine proteases such as neutrophil elastase cathepsin G and proteinase 3. The clinical manifestations of alpha1AT deficiency occur chiefly in the lung, with a high risk of emphysema occurring by the third or fourth decade of life. Cigarette smoking accelerates the development of emphysema in persons with alpha1AT deficiency. There is also an increased risk of liver disease in alpha1AT deficiency, which occurs mostly in childhood. In this review, we will define further the diagnosis of alpha1AT deficiency and its clinical manifestations and describe the therapeutic strategies that are currently being developed to treat the hepatic and pulmonary disease associated with this condition.


Assuntos
Deficiência de alfa 1-Antitripsina/fisiopatologia , alfa 1-Antitripsina/genética , Adulto , Mapeamento Cromossômico , Cromossomos Humanos Par 14 , Enfisema/epidemiologia , Enfisema/genética , Humanos , Elastase de Leucócito/antagonistas & inibidores , Hepatopatias/epidemiologia , Hepatopatias/genética , Pulmão/fisiopatologia , Fumar/efeitos adversos , alfa 1-Antitripsina/fisiologia , Deficiência de alfa 1-Antitripsina/complicações , Deficiência de alfa 1-Antitripsina/genética
3.
Am J Physiol Lung Cell Mol Physiol ; 279(1): L66-74, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10893204

RESUMO

Cystic fibrosis (CF) is a condition characterized by neutrophil-mediated lung damage and bacterial colonization. The physiological basis for reported functional alterations in CF neutrophils, including increased release of neutrophil elastase, myeloperoxidase, and oxidants, is unknown. These processes are, however, regulated by intracellular pH (pH(i)). We demonstrate here that pH(i) regulation is altered in neutrophils from CF patients. Although resting pH(i) is similar, pH(i) after acid loading and activation (N-formyl-methionyl-leucyl-phenylalanine and phorbol 12-myristate 13-acetate) is more acidic in CF cells than in normal cells. Furthermore, patients with non-CF-related bronchiectasis handle acid loading and activation in a fashion similar to subjects with normal neutrophils, suggesting that chronic pulmonary inflammation alone does not explain the difference in pH(i). This is further supported by data showing that normal neutrophils exposed to the CF pulmonary milieu respond by increasing pH(i) as opposed to decreasing pH(i) as seen in activated CF neutrophils. These pH(i) differences in activated or acid-loaded CF neutrophils are abrogated by ZnCl(2) but not by amiloride and bafilomycin A(1), suggesting that passive proton conductance is abnormal in CF. In addition, DIDS, which inhibits HCO(3)(-)/Cl(-) exchange, causes alkalinization of control but not of CF neutrophils, suggesting that anion transport is also abnormal in CF neutrophils. In summary, we have shown that pH(i) regulation in CF neutrophils is intrinsically abnormal, potentially contributing to the pulmonary manifestations of the condition.


Assuntos
Fibrose Cística/metabolismo , Hidrogênio/metabolismo , Membranas Intracelulares/metabolismo , Neutrófilos/metabolismo , Ácido 4,4'-Di-Isotiocianoestilbeno-2,2'-Dissulfônico/farmacologia , Ácidos/farmacologia , Adolescente , Adulto , Álcalis/metabolismo , Bronquiectasia/metabolismo , Bronquiectasia/patologia , Líquido da Lavagem Broncoalveolar/citologia , Cloretos/farmacologia , Fibrose Cística/patologia , Feminino , Humanos , Concentração de Íons de Hidrogênio , Masculino , Monócitos/fisiologia , Neutrófilos/efeitos dos fármacos , Prótons , Valores de Referência , Compostos de Zinco/farmacologia
4.
Am J Physiol Lung Cell Mol Physiol ; 278(1): L33-41, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10645888

RESUMO

Cystic fibrosis (CF) is a lethal, hereditary disorder characterized by a neutrophil-dominated inflammation of the lung. We sought to determine whether neutrophils from individuals with CF release more neutrophil elastase (NE) than neutrophils from normal subjects. Our results showed that peripheral blood neutrophils (PBNs) from normal subjects and individuals with CF contained similar amounts of NE, but after preincubation with CF bronchoalveolar lavage (BAL) fluid, significantly more NE was released by CF PBNs, a release that was amplified further by incubation with opsonized Escherichia coli. To determine which components of CF BAL fluid stimulated this excessive NE release from CF PBNs, we repeated the experiments after neutralization or immunoprecipitation of tumor necrosis factor (TNF)-alpha and interleukin (IL)-8 in CF BAL fluid. We found that subsequent NE release from CF PBNs was reduced significantly when TNF-alpha and IL-8 were removed from CF BAL fluid. When TNF-alpha and IL-8 were used as activating stimuli, CF PBNs released significantly greater amounts of NE compared with PBNs from control subjects and individuals with bronchiectasis. These results indicate that CF PBNs respond abnormally to TNF-alpha and IL-8 in CF BAL fluid and react to opsonized bacteria by releasing more NE. This may help explain the increased NE burden seen in this condition.


Assuntos
Fibrose Cística/metabolismo , Interleucina-8/fisiologia , Elastase de Leucócito/metabolismo , Fator de Necrose Tumoral alfa/fisiologia , Antígenos CD/metabolismo , Líquido da Lavagem Broncoalveolar/química , Criança , Pré-Escolar , Humanos , Interleucina-8/análise , Interleucina-8/farmacologia , Antígeno de Macrófago 1/metabolismo , Neutrófilos/efeitos dos fármacos , Neutrófilos/metabolismo , Norepinefrina/metabolismo , Testes de Precipitina , Isoformas de Proteínas/metabolismo , Receptores Fc/metabolismo , Receptores de Interleucina/metabolismo , Receptores de Interleucina-8A , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA